Similar articles

• Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

  Ezekowitz RA, Mulliken JB, Folkman J. Ezekowitz RA, et al. N Engl J Med. 1992 May 28;326(22):1456-63. doi: 10.1056/NEJM199205283262203. N Engl J Med. 1992. PMID: 1489383 Clinical Trial.
• The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids.

  Blei F, Isakoff M, Deb G. Blei F, et al. Arch Otolaryngol Head Neck Surg. 1997 Aug;123(8):841-4. doi: 10.1001/archotol.1997.01900080075009. Arch Otolaryngol Head Neck Surg. 1997. PMID: 9260550
• The use of interferon alfa-2a for life-threatening hemangiomas.

  MacArthur CJ, Senders CW, Katz J. MacArthur CJ, et al. Arch Otolaryngol Head Neck Surg. 1995 Jun;121(6):690-3. doi: 10.1001/archotol.1995.01890060088018. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7772325 Clinical Trial.
• Childhood cutaneous hemangiomas.

  Altman RS, Schwartz RA. Altman RS, et al. Cutis. 2003 Sep;72(3):201-5. Cutis. 2003. PMID: 14533831 Review.
• Which hemangiomas to treat--and how?

  Frieden IJ. Frieden IJ. Arch Dermatol. 1997 Dec;133(12):1593-5. Arch Dermatol. 1997. PMID: 9420551 Review. No abstract available.